SOAT1 and cancer: Consequently, their functions generate a pro-tumorigenic microenvironment thereby promoting self-renewal and differentiation of cancer stem cells as well as establishing the formation of pre-metastatic niche.[5,6] Accumulating evidence has demonstrated that inhibition of the JAK-STAT pathway is a potential target for drug development and immunotherapy in various cancers.